| Michael Badellino, MD | |
|
1240 S Cedar Crest Blvd, Suite 308, Allentown, PA 18103-6369 | |
| (610) 402-1350 | |
| (610) 402-1356 |
| Full Name | Michael Badellino |
|---|---|
| Gender | Male |
| Speciality | Surgery - Trauma Surgery |
| Location | 1240 S Cedar Crest Blvd, Allentown, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518974179 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0127X | Surgery - Trauma Surgery | MD033080E (Pennsylvania) | Primary |
| Entity Name | Lehigh Valley Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457309650 PECOS PAC ID: 3072425123 Enrollment ID: O20040227000335 |
News Archive
Shiriki Kumanyika, PhD, MPH, Professor of Epidemiology and Associate Dean for Health Promotion and Health Prevention, at the University of Pennsylvania School of Medicine, and Virginia A. Stallings, MD, PhD, the Jean A. Cortner Endowed Chair in Pediatric Gastroenterology at Penn and Professor of Pediatrics at The Children's Hospital of Philadelphia, will be part of a panel at a special public session, Understanding Obesity and Childhood at the 2008 American Association for the Advancement of Science (AAAS) annual meeting in Boston.
A case study published in the current issue of the American Journal of Health-System Pharmacists, demonstrates the positive impact of a diabetes management program designed to educate and motivate members to engage in their health care. The program was implemented by CVS Caremark and Polk County, Florida, a self-insured government employer client.
Regeneron and Bayer HealthCare announced initiation of a new Phase 3 clinical trial in collaboration with the Singapore Eye Research Institute investigating the efficacy and safety of VEGF Trap-Eye (aflibercept ophthalmic solution) in patients with choroidal neovascularisation (CNV) of the retina as a result of pathologic myopia.
Vanda Pharmaceuticals has announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for iloperidone, an investigational atypical antipsychotic for the treatment of schizophrenia.
In a recently released Patient Safety E-lert, the ECRI Institute Patient Safety Organization (PSO) highlights a patient safety issue involving cardiac monitoring of incorrect patients. The issue was brought to ECRI Institute PSO's attention in its analysis of reports submitted by participating healthcare providers.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Badellino, MD Po Box 783311, Philadelphia, PA 19178-3311 Ph: () - | Michael Badellino, MD 1240 S Cedar Crest Blvd, Suite 308, Allentown, PA 18103-6369 Ph: (610) 402-1350 |
News Archive
Shiriki Kumanyika, PhD, MPH, Professor of Epidemiology and Associate Dean for Health Promotion and Health Prevention, at the University of Pennsylvania School of Medicine, and Virginia A. Stallings, MD, PhD, the Jean A. Cortner Endowed Chair in Pediatric Gastroenterology at Penn and Professor of Pediatrics at The Children's Hospital of Philadelphia, will be part of a panel at a special public session, Understanding Obesity and Childhood at the 2008 American Association for the Advancement of Science (AAAS) annual meeting in Boston.
A case study published in the current issue of the American Journal of Health-System Pharmacists, demonstrates the positive impact of a diabetes management program designed to educate and motivate members to engage in their health care. The program was implemented by CVS Caremark and Polk County, Florida, a self-insured government employer client.
Regeneron and Bayer HealthCare announced initiation of a new Phase 3 clinical trial in collaboration with the Singapore Eye Research Institute investigating the efficacy and safety of VEGF Trap-Eye (aflibercept ophthalmic solution) in patients with choroidal neovascularisation (CNV) of the retina as a result of pathologic myopia.
Vanda Pharmaceuticals has announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for iloperidone, an investigational atypical antipsychotic for the treatment of schizophrenia.
In a recently released Patient Safety E-lert, the ECRI Institute Patient Safety Organization (PSO) highlights a patient safety issue involving cardiac monitoring of incorrect patients. The issue was brought to ECRI Institute PSO's attention in its analysis of reports submitted by participating healthcare providers.
› Verified 1 days ago
Robert D Barraco, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1240 S Cedar Crest Blvd, Suite 308, Allentown, PA 18103 Phone: 610-402-1350 Fax: 610-402-1356 | |
Rovinder Singh Sandhu, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1240 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-402-1350 | |
Dr. Daniel Ryan Latta, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-482-8000 | |
Heiwon Chung, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1240 S Cedar Crest Blvd, Suite 205, Allentown, PA 18103 Phone: 610-402-7884 | |
Heather Lynn Geist, MD Surgery Medicare: Medicare Enrolled Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-402-8000 | |
Dr. Marissa Lynn Dallara, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-402-8000 | |
William D Hardin Jr., MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1259 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-402-1259 |